Literature DB >> 14699151

Interaction of bcl-2 with Paxillin through its BH4 domain is important during ureteric bud branching.

Christine M Sorenson1.   

Abstract

bcl-2 protects cells from apoptosis initiated by a variety of stimuli including loss of cell adhesion. Mice deficient in bcl-2 (bcl-2-/-) develop renal hypoplastic/cystic dysplasia, a condition that leads to significant morbidity and mortality in children. The precise mechanism of action of bcl-2 has not been elucidated. bcl-2 may merely facilitate survival of precursor cells and/or may play a more "active" role during morphogenesis by interacting with other proteins such as paxillin. Recent work in this laboratory demonstrated that bcl-2 directly associates with paxillin. The data presented here demonstrate that the bcl-2 homology 4 (BH4) domain, specifically amino acids 17-31, is necessary for the bcl-2 interaction with paxillin. Paxillin also associated with the BH4 domains of more closely related bcl-2 family members, bcl-xL and bcl-w, compared with that from the non-mammalian homologue ced9. Tyrosines 21 and 28 in the bcl-2 BH4 domain were essential for interaction with paxillin. In embryonic kidney organ culture, incubation with the bcl-2 BH4 domain resulted in inhibition of ureteric bud branching. Therefore, these data suggest that the interaction of bcl-2 with paxillin plays an important role during nephrogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699151     DOI: 10.1074/jbc.M310079200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Opposing effects of bim and bcl-2 on lung endothelial cell migration.

Authors:  Cathy Grutzmacher; SunYoung Park; Tammy L Elmergreen; Yixin Tang; Elizabeth A Scheef; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

Review 2.  Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.

Authors:  Yi-Ping Rong; Paul Barr; Vivien C Yee; Clark W Distelhorst
Journal:  Biochim Biophys Acta       Date:  2008-11-12

3.  Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.

Authors:  Gautier Moroy; Elyette Martin; Annick Dejaegere; Roland H Stote
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

Review 4.  Kidney and urinary tract development: an apoptotic balancing act.

Authors:  Katherine Stewart; Maxime Bouchard
Journal:  Pediatr Nephrol       Date:  2011-03-02       Impact factor: 3.714

5.  Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.

Authors:  Lianqing Li; Jing Wang; Lei Gao; Lili Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

6.  BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization.

Authors:  Hengning Ke; Vandy I Parron; Jeff Reece; Jennifer Y Zhang; Steven K Akiyama; John E French
Journal:  Cell Res       Date:  2010-02-09       Impact factor: 25.617

7.  Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.

Authors:  Ramasamy Jagadeeswaran; Hanna Surawska; Soundararajan Krishnaswamy; Varalakshmi Janamanchi; A Craig Mackinnon; Tanguy Y Seiwert; Sivakumar Loganathan; Rajani Kanteti; Trevor Reichman; Vidya Nallasura; Stuart Schwartz; Leonardo Faoro; Yi-Ching Wang; Luc Girard; Maria S Tretiakova; Salman Ahmed; Osvaldo Zumba; Lioubov Soulii; Vytas P Bindokas; Livia L Szeto; Gavin J Gordon; Raphael Bueno; David Sugarbaker; Mark W Lingen; Martin Sattler; Thomas Krausz; Wickii Vigneswaran; Viswanathan Natarajan; John Minna; Everett E Vokes; Mark K Ferguson; Aliya N Husain; Ravi Salgia
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

Review 8.  BH4 domain of Bcl-2 as a novel target for cancer therapy.

Authors:  Zhiqing Liu; Christopher Wild; Ye Ding; Na Ye; Haiying Chen; Eric A Wold; Jia Zhou
Journal:  Drug Discov Today       Date:  2015-11-26       Impact factor: 7.851

Review 9.  Paxillin comes of age.

Authors:  Nicholas O Deakin; Christopher E Turner
Journal:  J Cell Sci       Date:  2008-08-01       Impact factor: 5.285

10.  Rescue of renal hypoplasia and cystic dysplasia in Bcl-2 -/- mice expressing Bcl-2 in ureteric bud derived epithelia.

Authors:  Shuji Kondo; Mason G Oakes; Christine M Sorenson
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.